Covishield Export Resumes, Serum Institute Crosses 1 Billion Vaccine Mark
NDTV
Serum Institute of India chief executive Adar Poonawalla said the world has largely depended on the low-cost, high-quality pharmaceuticals and vaccines that India has traditionally exported
Covishield-maker Serum Institute of India has resumed vaccine exports for distribution to low- and middle-income nations under the global vaccine-sharing programme COVAX.
In a statement, Serum Institute of India, or SII, chief executive Adar Poonawalla said the world has largely depended on the low-cost, high-quality pharmaceuticals and vaccines that India has traditionally exported. "We are delighted to support the global vaccination effort once more," Mr Poonawalla said.
The total number of Covishield doses manufactured so far has crossed the 1.25 billion mark, according to the Pune-headquartered company.
The first batches of Covishield marked for exports left the SII's Pune facility this morning. The company expects its vaccine exports to increase substantially by the first quarter of 2022.
